Based on the GlaxoSmithKline PLC stock forecast from 1 analysts, the average analyst target price for GlaxoSmithKline PLC is GBX 1,850.00 over the next 12 months. GlaxoSmithKline PLC’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of GlaxoSmithKline PLC is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, GlaxoSmithKline PLC’s stock price was GBX 1,429.00. GlaxoSmithKline PLC’s stock price has changed by -0.42% over the past week, +4.80% over the past month and -14.55% over the last year.
No recent analyst target price found for GlaxoSmithKline PLC
No recent average analyst rating found for GlaxoSmithKline PLC
Company Overview GlaxoSmithKline PLC
N/A
N/A
N/A
N/A
GBX
UK
Adjusted Closing Price for GlaxoSmithKline PLC (GSK:LSE)
Loading...
Unadjusted Closing Price for GlaxoSmithKline PLC (GSK:LSE)
Loading...
Share Trading Volume for GlaxoSmithKline PLC Shares
Frequently Asked Questions About GlaxoSmithKline PLC (GSK:LSE) Stock
Based on ratings from 1 analysts GlaxoSmithKline PLC's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on GSK:LSE's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for GSK:LSE is GBX 1,850.00 over the next 12 months. The maximum analyst target price is GBX 1850 while the minimum anlayst target price is GBX 1850.
Unfortunately we do not have enough data on GSK:LSE's stock to indicate if its overvalued.
The last closing price of GSK:LSE's stock was GBX 1,429.00.
Unfortunately we do not currently have any market capitalization data for GSK:LSE's stock.
Based on targets from 1 analysts, the average taret price for GSK:LSE is projected at GBX 1,850.00 over the next 12 months.
This means that GSK:LSE's stock price may go up by +29.46% over the next 12 months.
We can't find any ETFs which contains GlaxoSmithKline PLC's stock.
Sorry, we do not have any data on the number of employees for GlaxoSmithKline PLC.
Sorry we do not have any infomation available on GlaxoSmithKline PLC's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About GlaxoSmithKline PLC (GSK:LSE) Stock
Based on ratings from 1 analysts GlaxoSmithKline PLC's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on GSK:LSE's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for GSK:LSE is GBX 1,850.00 over the next 12 months. The maximum analyst target price is GBX 1850 while the minimum anlayst target price is GBX 1850.
Unfortunately we do not have enough data on GSK:LSE's stock to indicate if its overvalued.
The last closing price of GSK:LSE's stock was GBX 1,429.00.
Unfortunately we do not currently have any market capitalization data for GSK:LSE's stock.
Based on targets from 1 analysts, the average taret price for GSK:LSE is projected at GBX 1,850.00 over the next 12 months.
This means that GSK:LSE's stock price may go up by +29.46% over the next 12 months.
We can't find any ETFs which contains GlaxoSmithKline PLC's stock.
Sorry, we do not have any data on the number of employees for GlaxoSmithKline PLC.
Sorry we do not have any infomation available on GlaxoSmithKline PLC's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GSK:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
